HKSH Cancer Centre
Proton Therapy
Training Programme
Proton Therapy
Joint Training Course
PTCOG-AO2025



The Proton Therapy Joint Training Course co-organised by the HKSH Cancer Centre and the National Cancer Center was successfully held at the Beijing International Hotel on 21 and 22 June. The course aims to advance the clinical application of proton therapy, elevate cancer treatment standards in China, and foster international exchange and collaboration in medical technology. The event attracted medical professionals from across the country, including Hong Kong. Featuring inspiring keynote speeches, case studies, and experience-sharing sessions delivered by authoritative experts from mainland China, Hong Kong and the United States, the course provided a platform for in-depth discussions on the latest advancements and clinical applications of proton therapy, enabling participants to deepen their understanding of this cutting-edge technology and gain valuable insights into the practical application in their work.



As a global leading cancer management institution, the HKSH Cancer Centre launched the first proton therapy centre in the Greater Bay Area in 2023. The HKSH Proton Centre has so far successfully processed over 400 cases, accumulating valuable clinical experience.


Reflecting on the challenges of constructing the HKSH Proton Therapy Centre, Mr. Wyman LI, Chief Operating Officer of HKSH Medical Group and Director of Hong Kong Sanatorium & Hospital, said, "We overcame two major challenges. First, we have installed the world’s first vertically positioned proton therapy system within limited space. Second, we have nurtured a highly professional team with international calibre through more than a decade of dedicated efforts. Over the years, we have engaged in extensive collaborations with the world’s leading institutions, including Mayo Clinic, MD Anderson Cancer Centre, Massachusetts General Hospital, and the University of Florida Health through in-depth exchanges and talent development programmes."



Professor Jie HE, Head of the National Cancer Centre and President of the Cancer Hospital, Chinese Academy of Medical Sciences, delivered the opening address

Mr. Wyman LI, Chief Operating Officer of HKSH Medical Group, Director of Hong Kong Sanatorium & Hospital, and Governor of The Li Shu Fan Medical Foundation, delivered his opening remarks

The two-day training course was divided into eight main modules, covering the fundamental principles of proton therapy, technological advancements, and clinical applications in cancer treatment. The curriculum was designed to integrate theories and practice, providing detailed insights into critical technical issues, clinical operational standards as well as the latest research development, while helping participants better understand the core technologies of proton therapy and its potential applications in treating different types of tumour.

The training not only addressed current clinical challenges in proton therapy but also explored cutting-edge topics and future development directions, offering participants comprehensive and multi-dimensional professional perspectives. The course was carefully designed to meet various needs of participants from diverse professional backgrounds, ensuring oncologists, medical physicists, and radiotherapists can all benefit from it and laying a solid foundation for the wider adoption and application of proton therapy.

Highlights from the Training Sessions


Slide 1

Professor Junlin YI from Cancer Hospital, Chinese Academy of Medical Sciences, delivered an in-depth analysis on “The Uncertainties and Solutions of Proton Therapy in Head and Neck Cancer”, helping participants better understand the clinical challenges and solutions associated with this technology.

Slide 2

In the session on “CT Curve Model in Proton Therapy”, Dr. Kimi YANG, medical physicist from the HKSH Cancer Centre, shared practical insights on how to establish the CT curve in treatment planning system.

Slide 3

Dr. Kimi YANG continued the session on “Robust Planning in Proton Therapy”, focusing on the basic concept and application of robust planning.

Slide 4

Dr Xinyuan CHEN from Cancer Hospital, Chinese Academy of Medical Sciences, explored the “Potential Applications of Magnetic Resonance Biomarkers in Proton Therapy” during her session, discussing the promising future of integrating magnetic resonance imaging into proton therapy.

Slide 5

In the “Proton Therapy in Breast Cancer” session, Dr. Amy TY CHANG from the HKSH Cancer Centre shared treatment planning and clinical consideration for applying proton therapy in breast cancer. Following this, dosimetrist Ms. Winky WK FUNG and radiation therapist Ms. Chloe YY CHAN from the HKSH Cancer Centre, further elaborated on the procedural details for patients undergoing proton therapy.

Slide 6

The session on “Commissioning and Routine Quality Assurance of Proton Therapy Systems” was led by Mr Hui GENG from the HKSH Cancer Centre, who provided a comprehensive explanation on proton therapy machine commissioning and quality control.

Slide 7

During the “Proton Therapy in Head and Neck Cancer”, Dr. Stephen CK LAW, along with Ms. Chloe YY CHAN (radiation therapist), Ms. Winky WK FUNG (dosimetrist), and Dr Kimi YANG (medical physicist), from the HKSH Cancer Centre, presented case studies to demonstrate the value and practical experience of this technology.

Slide 8

To conclude the training, Professor Terence SIO, Vice Chair of Mayo Clinic AZ, delivered a session on “Advanced Topics & Future of Proton Therapy,” providing participants with valuable insights into the cutting-edge research and technological advancements shaping the future of the field.

Slide 9

Dr. Simon TANG from the HKSH Cancer Centre delivered the opening and closing speeches, sharing insights into the latest trends in the development of proton therapy in China. As Chair of the Organising Committee, he also invited all participants to attend the 5th Annual Conference of Asia-Oceania Particle Therapy Cooperative Group (PTCOG-AO), which will be held in Hong Kong from November 7 to 9, 2025.


Go Top